7月17日，科济药业-B盘中下跌6.03%，报15.91港元/股，成交额1668.33万港元。
科济药业-B所在的生物科技行业整体走弱，个股中，康方生物跌8.5%，三生制药跌7.65%，科伦博泰生物跌4.69%，信达生物跌3.03%，百济神州跌2.36%。
科济药业控股有限公司是一家主要从事探索、研发细胞疗法的投资控股公司，主营业务为开发CAR-T细胞疗法，覆盖血液恶性肿瘤、实体瘤及自身免疫性疾病领域，主要产品包括赛恺泽、舒瑞基奥仑赛注射液及通用型CAR-T细胞产品。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.